Nexvet : Looking after (wo)man’s best friend…

My name is Chris Behrenbruch, and I live with a cat named Kuzya. In case you have wondered why I started this post this way, I figured after taking a look at Nexvet’s management bios on the company website, I would lack credibility if I didn’t also disclose my relationship to the aforementioned moggy. To…

ResMed – An Alternative Perspective

I wouldn’t normally comment on ResMed because I don’t consider it to be an “Australian” company any more, nor with its current multi-$Bn valuation is it in the “long tail” of the ASX either… But I was thinking a lot about ResMed over the weekend for basically two reasons. Firstly, I previously, with some degree…

No Bacon in BLT

What do you think of my bacon gene silencing gag, pretty cool eh? I do love the sizzle of bacon… Firstly, I would like to start this blog post by apologising to Benitec, and particularly Peter French (CEO). In my last entry, I broke one of my own purported rules and that was not to…

Orthocell : Love Me Tendon, Love Me True…

In a previous post, I discussed the potential risk to the “quackery” end of Australia’s stem cell medicine industry if the TGA ever had a change of heart about how autologous (“from self”) cell therapies are regulated. At one end of the spectrum we have proven cell therapies that have been saving lives for a long…